Company intelligence / Profile preview

Stirling Anglian Pharmaceuticals

Glasgow, Scotland, United Kingdom

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Stirling Anglian Pharmaceuticals focuses on the development and commercialization of 'value-added' medicines, which are typically off-patent drugs reformulated to provide better patient outcomes or cost-effectiveness. Their current portfolio is fully commercialized within the UK healthcare market.

Therapeutic areas: PsychiatryCardiovascularEndocrinologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Partnerships

Apposite Capital

Beyond the preview

Go deeper on Stirling Anglian Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stirling Anglian Pharmaceuticals.

Explore the full profile